1D·
11
3 Comentários

imagem de perfil
$HIMS will drop good numbers but the outlook will be bad after the FDA news
1
imagem de perfil
@Caynify i hope the price will not drop
@Caynify I think that if things go well, it will only go down to around €38-40. And that is independent of the reported figures. The share has risen massively in recent weeks without any fundamental news to justify a rise of 77% on a monthly basis. This short rally will be sold off again. The figures will only decide how far it goes in my opinion. Long-term investors should buy in 2 tranches. The first below €40 and the second below €30, so a bottom should be found at 27 at the latest.
1
Participar na conversa